Advertisement
A once-daily

Triple Therapy Cuts Mortality in Patients With Symptomatic COPD

0
All-cause mortality risk significantly lower for triple-drug regimen versus one of two dual-drug regimens
Americans' understanding of safety measures to protect themselves from COVID-19 is increasing

More Americans Recognizing Importance of COVID-19 Safety Measures

0
Yet many Americans still believe they have little chance of catching the virus
Management of elective surgical procedures in the setting of coronavirus disease 2019 is addressed in two sets of recommendations published by the American College of Surgeons.

Management of Elective Surgery Reviewed in Setting of COVID-19

0
Two sets of recommendations relate to management of elective surgery, triage of nonemergent operations
From 2017 to 2018

CDC: Modest Decreases Seen in TB Cases, TB-Related Deaths

0
From 2017 to 2018, 2 and 5 percent declines seen in incident TB and TB-related deaths, respectively
Management of cancer care during the coronavirus 2019 pandemic is addressed in a special feature article published online March 20 in the Journal of the National Comprehensive Cancer Network.

Article Addresses Management of Cancer Care During COVID-19

0
Patient information should be provided; well visits should be rescheduled, transitioned to telemedicine
A considerable proportion of health care workers caring for patients with coronavirus disease 2019 report symptoms of depression

Mental Health at Risk for Health Care Workers Treating COVID-19

0
Nurses, women, frontline health care workers caring for COVID-19 patients at greater mental health risk
The incidence of subclinical computed tomography (CT) changes in coronavirus 2019 cases is high

Incidence of Subclinical CT Changes High in COVID-19 Cases

0
Milder severity seen on CT for asymptomatic versus symptomatic Diamond Princess cruise ship cases
The incidence of developing tuberculosis is high among exposed infants and young children

Incidence of Tuberculosis High in Children Exposed to the Disease

0
Preventive therapy effective in most TB-infected children if given before development of active disease
Lopinavir-ritonavir treatment offers no significant benefit over standard care for hospitalized adult patients with severe coronavirus 2019 infection

Lopinavir-Ritonavir No Benefit in Adults With Severe COVID-19

0
No benefit seen in time to clinical improvement, mortality at 28 days compared with standard care alone
Patients already prescribed angiotensin-converting enzyme inhibitors or angiotensin receptor blockers should continue taking their medications

Statement Addresses Concerns About Heart Meds and COVID-19

0
Patients advised to continue ACE inhibitors/ARBs after researcher posits risk for severe COVID-19 infection